The molecular basis of prostate cancer
- PMID: 16308946
- DOI: 10.12968/hmed.2005.66.11.20021
The molecular basis of prostate cancer
Abstract
Cancer involves accumulation of genetic alterations. This review highlights the alterations in control pathways for cell division, development, DNA repair, angiogenesis and cell death that are believed to be key players in the development of prostate cancer.
Similar articles
-
Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer.Cancer Res. 2005 Apr 15;65(8):2990-2. doi: 10.1158/0008-5472.CAN-05-0439. Cancer Res. 2005. PMID: 15833820 Review.
-
Cancer genes and the pathways they control.Nat Med. 2004 Aug;10(8):789-99. doi: 10.1038/nm1087. Nat Med. 2004. PMID: 15286780 Review.
-
In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.Oncogene. 2002 Apr 18;21(17):2679-94. doi: 10.1038/sj.onc.1205352. Oncogene. 2002. PMID: 11965541
-
Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch.Cell Cycle. 2012 Dec 1;11(23):4344-51. doi: 10.4161/cc.22134. Epub 2012 Oct 3. Cell Cycle. 2012. PMID: 23032367 Free PMC article. Review.
-
The works of GLI and the power of hedgehog.Nat Cell Biol. 1999 Oct;1(6):E147-8. doi: 10.1038/14099. Nat Cell Biol. 1999. PMID: 10559974 No abstract available.
Cited by
-
Inhibition of prostatic cancer growth by ginsenoside Rh2.Tumour Biol. 2015 Apr;36(4):2377-81. doi: 10.1007/s13277-014-2845-5. Epub 2014 Nov 23. Tumour Biol. 2015. PMID: 25416441
-
Targeting SMAD3 for inhibiting prostate cancer metastasis.Tumour Biol. 2014 Sep;35(9):8537-41. doi: 10.1007/s13277-014-2368-0. Epub 2014 Jul 24. Tumour Biol. 2014. PMID: 25056536
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical